Cat.#: ACPP-1329
| Despition | PDE6 Beta Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1038 | Recombinant Human VCAM1 Protein (6×His Tag) (AC1038) | 50 µg | inquiry |
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
| ACPP-1618 | Human SYT11 Protein (AC1618) | 2 µg | inquiry |
| ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
| ACPP-1710 | Mouse CALB2 Protein (AC1710) | 2 µg | inquiry |
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1476 | Human ENSA Protein (AC1476) | 5 µg | inquiry |
| ACPP-1180 | Native Human Luteinizing Hormone (Functional) (AC1180) | 100 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.